Table 1. Comparison of Clinicopathological Features in the Adenoma and EGC Groups.
| Total | Adenoma group | EGC group | P-value | |
|---|---|---|---|---|
| Number | 146 | 56 (38.4) | 90 (61.6) | |
| Age, year (mean ± SD) | 63.0 ± 8.6 | 61.7 ± 8.0 | 63.8 ± 8.9 | 0.150 |
| Gender, male (%) | 104 (71.2) | 36 (64.3) | 68 (75.6) | 0.144 |
| Family history of gastric cancer (%) | 27 (18.6) | 9 (16.1) | 18 (20.2) | 0.532 |
| Smoking (%) | 85 (58.2) | 31 (55.4) | 54 (60.0) | 0.580 |
| Alcohol consumption (%) | 50 (34.2) | 15 (26.8) | 35 (38.9) | 0.134 |
| H. pylori infection (%) | 90 (61.6) | 35 (62.5) | 55 (61.1) | 0.867 |
| Tumor size, cm (mean ± SD) | 1.7 ± 1.2 | 1.6 ± 1.4 | 1.8 ± 1.1 | 0.287 |
| Tumor location | 0.861 | |||
| Upper third | 7 (4.8) | 2 (3.6) | 5 (5.6) | |
| Middle third | 23 (15.8) | 9 (16.1) | 14 (15.6) | |
| Lower third | 116 (79.5) | 45 (80.4) | 71 (78.9) | |
| Multiplicity | 26 (17.8) | 9 (16.1) | 17 (18.9) | 0.665 |
| Serologic atrophya (%) | 27 (18.5) | 13 (23.2) | 14 (15.6) | 0.246 |
EGC, early gastric cancer.
Continuous variables are presented as means ± SD.
a Serological atrophy was defined as pepsinogen A < 25 μg/L and/or a pepsinogen A / progastricsin ratio < 3.